Online Now: Putting the STING back into BH3-mimetic drugs for TP53-mutant blood cancers dlvr.it/T63sGn

Online Now: Molecular subtypes as potential biomarkers in renal cell carcinoma dlvr.it/T63DtX

Online Now: A temporal perspective for tumor-associated macrophage identities and functions dlvr.it/T61jZN

Online Now: Tumor cell-intrinsic epigenetic SETpoint of cancer-associated fibroblasts dlvr.it/T61F5H

Online Now: Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization dlvr.it/T5hSH7

Online Now: The crosstalk between macrophages and cancer cells potentiates pancreatic cancer cachexia dlvr.it/T5YKv0

Targeting APOBECs in cancer: It’s about timing dlvr.it/T5XsTP

The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions dlvr.it/T5XG7B

Pharmacogenomic profiling of intra-tumor heterogeneity using a large organoid biobank of liver cancer dlvr.it/T5RJry

Single-cell systems pharmacology identifies development-driven drug response and combination therapy in B cell acute lymphoblastic leukemia dlvr.it/T5QvYV

Genetic interactions reveal distinct biological and therapeutic implications in breast cancer dlvr.it/T5QM2H

Mapping functional to morphological variation reveals the basis of regional extracellular matrix subversion and nerve invasion in pancreatic cancer dlvr.it/T5Nyb7

The liver as a cytokine factory working on mRNA blueprints for cancer immunotherapy dlvr.it/T5NVls

Long-lasting mRNA-encoded interleukin-2 restores CD8+ T cell neoantigen immunity in MHC class I-deficient cancers dlvr.it/T5MwQV

Multimodal stimulation screens reveal unique and shared genes limiting T cell fitness dlvr.it/T5LWhM

SWI/SNF regulation of germinal center fate and lymphomagenesis dlvr.it/T5L1hr

Unraveling a hidden player in lymphovascular invasion in bladder cancer dlvr.it/T5KRKc

ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis dlvr.it/T5J2kT

SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisions dlvr.it/T5HbCT

Unleashing a safe and potent pro-senescence anti-tumor strategy dlvr.it/T5H0yF